A national study of physician recommendations to initiate and discontinue growth hormone for short stature

Pediatrics

Volumn 126, Issue 3, 2010, Pages 468-476

  Silvers, J B ^a,b   Marinova, Detelina ^c   Mercer, Mary Beth ^b   Connors, Alfred ^a   Cuttler, Leona ^b  

^a METROHEALTH MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

Children; Growth hormone; Medication use; Physician decision making; Short stature

Indexed keywords

GROWTH HORMONE;

ARTICLE; CLINICAL DECISION MAKING; CONSENSUS; COST EFFECTIVENESS ANALYSIS; DRUG DOSE INCREASE; EVIDENCE BASED MEDICINE; FACTORIAL DESIGN; FEMALE; HORMONAL THERAPY; HUMAN; IDIOPATHIC DISEASE; MALE; MARKET; PHYSICIAN; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHORT STATURE; STRUCTURED QUESTIONNAIRE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; WELLBEING; CHILD; CLINICAL PRACTICE; ENDOCRINOLOGY; GROWTH DISORDERS; PEDIATRICS; QUESTIONNAIRE; UNITED STATES;

CHILD; ENDOCRINOLOGY; FEMALE; GROWTH DISORDERS; GROWTH HORMONE; HUMANS; MALE; PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; UNITED STATES;

EID: 77956270153     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2009-3609     Document Type: Article

References (45)

1. US Food and Drug Administration. Approval letter for application number NDA 19-640/S-033: Humatrope; July 25, 2003. Available at: www.accessdata.fda. gov/drugsatfda-docs/appletter/2003/19640se1-033ltr.pdf. Accessed July 26, 2010
2. Cuttler L, Silvers JB. Growth hormone treatment for idiopathic short stature: implications for practice and policy. Arch Pediatr Adolesc Med. 2004;158(2):108-110 (Pubitemid 38173961)
3. Cuttler L, Marinova D, Mercer MB, Connors A, Meehan R, Silvers JB. Patient, physician, and consumer drivers: referrals for short stature and access to specialty drugs. Med Care. 2009;47(8):858-865
4. Finkelstein BS, Imperiale TF, Speroff T, Marrero U, Radcliffe DJ, Cuttler L. Effect of growth hormone therapy on height in children with idiopathic short stature: a meta-analysis. Arch Pediatr Adolesc Med. 2002;156(3):230-240
5. Lee JM, Davis MM, Clark SJ, Hofer TP, Kemper AR. Estimated cost-effectiveness of growth hormone therapy for idiopathic short stature. Arch Pediatr Adolesc Med. 2006;160(3):263-269
6. Kelly CJ, Mir FA. Economics of biological therapies. BMJ. 2009;339:b3276
7. Goldman DP, Joyce GF, Lawless G, Crown WH, Willey V. Benefit design and specialty drug use. Health Aff (Millwood). 2006;25(5):1319-1331 (Pubitemid 44497632)
8. Golenski JD. Specialist discretion for managing specialty pharmaceuticals: the ethics argument for discretion. Am J Manag Care. 2004;10(suppl 8):S240-S241
9. Lee TH, Emanuel EJ. Tier 4 drugs and the fraying of the social compact. N Engl J Med. 2008;359(4):333-335
10. Mullins CD, DeVries AR, Hsu VD, Meng F, Palumbo FB. Variability and growth in spending for outpatient specialty pharmaceuticals. Health Aff (Millwood). 2005;24(4):1117-1127
11. Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr. 1952;40(4):423-441
12. Greulich W, Pyle S. Radiographic Atlas of Skeletal Development of the Hand and Wrist. 2nd ed. Palo Alto, CA: Stanford University Press; 1959
13. Cuttler L, Silvers JB, Singh J, et al. Short stature and growth hormone therapy: a national study of physician recommendation patterns. JAMA. 1996;276(7):531-537
14. Wyatt DT, Mark D, Slyper A. Survey of growth hormone treatment practices by 251 pediatric endocrinologists. J Clin Endocrinol Metab. 1995;80(11):3292- 3297
15. Alter C. Growth hormone for idiopathic short stature: whether and when to treat. Endocrine News. 2006;October:12-15
16. Bercu BB. The growing conundrum; growth hormone treatment of the nongrowth hormone-deficient child. JAMA. 1996;276(7):567-568
17. Frasier SD. An attempt at synthesis. J Clin Endocrinol Metab. 1994;79(5):1246-1248
18. Lee MM. Idiopathic short stature. N Engl J Med. 2006;354(24):2576-2582
19. Underwood LE. Growth hormone therapy for short stature: yes or no? Hosp Pract (Off Ed). 1992;27(4):192-196, 198
20. Cohen P, Rogol AD, Deal CL, et al. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab. 2008;93(11):4210-4217
21. Bakker B, Frane J, Anhalt H, Lippe B, Rosenfeld RG. Height velocity targets from the national cooperative growth study for firstyear growth hormone responses in short children. J Clin Endocrinol Metab. 2008;93(2):352-357 (Pubitemid 351240802)
22. Cohen P, Rogol AD, Howard CP, et al. Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study. J Clin Endocrinol Metab. 2007;92(7):2480-2486
23. Baron J. Growth hormone therapy in childhood: titration versus weight-based dosing? J Clin Endocrinol Metab. 2007;92(7):2436-2438
24. André M, Hedin K, Hakansson A, Molstad S, Rodhe N, Petersson C. More physician consultations and antibiotic prescriptions in families with high concern about infectious illness: adequate response to infectionprone child or self-fulfilling prophecy? Fam Pract. 2007;24(4):302-307
25. Epstein AM, Read JL, Winickoff R. Physician beliefs, attitudes, and prescribing behavior for anti-inflammatory drugs. Am J Med. 1984;77(2):313-318 (Pubitemid 14098642)
26. Feldman HA, McKinlay JB, Potter DA, et al. Nonmedical influences on medical decision making: an experimental technique using videotapes, factorial design, and survey sampling. Health Serv Res. 1997;32(3):343-366
27. Yu SM, Bellamy HA, Kogan MD, Dunbar JL, Schwalberg RH, Schuster MA. Factors that influence receipt of recommended preventive pediatric health and dental care. Pediatrics. 2002;110(6). Available at: www.pediatrics.org/cgi/ content/full/110/6/e73
28. Ferrándiz JM. The impact of generic goods in the pharmaceutical industry. Health Econ. 1999;8(7):599-612
29. Saha A, Grabowski H, Birnbaum H, Greenberg P, Bizan O. Generic competition in the US pharmaceutical industry. Int J Econ Bus. 2006;13:15-38
30. Dillman DA. Mail and Internet Surveys: The Tailored Design Method. 2nd ed. Hoboken, NJ: John Wiley and Sons; 2006
31. Greene WH. Econometric Analysis. 6th ed: Upper Saddle River, NJ: Prentice Hall; 2008
32. Bergeson SC, Dean JD. A systems approach to patient-centered care. JAMA. 2006;296(23):2848-2851
33. Institute of Medicine Committee on Quality of Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001
34. Miser WF. An introduction to evidence-based medicine. Prim Care. 2006;33(4):811-829
35. Institute of Medicine. The Learning Healthcare System: Workshop Summary. Olsen L, Aisner D, McGinnis JM, eds. Washington, DC: National Academies Press; 2007
36. Cohen P, Bright GM, Rogol AD, Kappelgaard AM, Rosenfeld RG. Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safety. J Clin Endocrinol Metab. 2002;87(1):90-98
37. Harvey N. Use of heuristics: insights from forecasting research. Think Reason. 2007;13:5-24
38. Kahneman D, Tversky A. Prospect theory: an analysis of decision under risk. Econometrica. 1979;47(2):263-291
39. Montgomery H. The psychology of economic forecasting: a possibility for cooperation between judgment and decision making and naturalistic decision-making theories? In: Montgomery H, Brehmer, B, eds. How Professionals Make Decisions. Mahwah, NJ: Lawrence Erlbaum; 2005:119-122
40. Tversky A, Kahneman D. The framing of decisions and the psychology of choice. Science. 1981;211(4481):453-458 (Pubitemid 11265613)
41. Epley N, Gilovich T. The anchoring-and-adjustment heuristic: why the adjustments are insufficient. Psychol Sci. 2006;17(4):311-318 (Pubitemid 43430220)
42. Hammond JS, Keeney RL, Raiffa H. The hidden traps in decision making. Harv Bus Rev. 1998;76(5):47-48, 50, 52 passim
43. Knecht S, Reinholz J, Kenning P. The spread of obesity in a social network. N Engl J Med. 2007;357(18):1866-1867; author reply 1867-1868
44. Senay I, Kaphingst KA. Anchoring-and-adjustment bias in communication of disease risk. Med Decis Making. 2009;29(2):193-201
45. Tversky A, Kahneman D. Judgment under uncertainty: heuristics and biases. Science. 1974;185(4157):1124-1131